• Lithium, Exosomal Wnt10a, and Bone Regeneration

  2026-10-07

  The 2024 ACS Applied Materials & Interfaces study identifies a mechanistic link between lithium exposure, Rab11a-dependent exosomal Wnt10a secretion, and activation of the Wnt/β-catenin signaling pathway in bone mesenchymal stem cells. Its findings suggest that lithium-engineered exosomes and GelMA-based delivery systems may improve osteogenic activity, while also highlighting important limits when translating pathway observations into therapeutic claims.

• Mubritinib (TAK 165): Mechanism and Evidence

  2026-10-07

  Mubritinib, also known as TAK 165, is best interpreted as a mitochondrial complex I inhibitor with context-dependent activity in AML and KSHV-positive PEL models. The available dossier supports mechanistic and preclinical research use, but it does not establish clinical efficacy or provide enough assay detail for direct protocol replication.

• Microbiota–AhR Axis in Ulcerative Colitis Repair

  2026-10-06

  Li et al. describe a microbiota–tryptophan metabolite–AhR–intestinal stem cell axis that may explain how Huangqin decoction supports mucosal repair in a mouse model of ulcerative colitis. The study combines microbiome, metabolite, pathway, and epithelial differentiation evidence, while leaving important questions about cell-specific causality and translation to human disease.

• Homoharringtonine and SARS-CoV-2: Study Evidence

  2026-10-06

  The reference study evaluates homoharringtonine across cell-based assays, animal models, and two early human cohorts, reporting inhibition of multiple coronaviruses and rapid SARS-CoV-2 clearance signals. Its main contribution is a cross-scale translational case for further investigation, although small, non-randomized patient groups and limited safety data prevent the findings from establishing clinical efficacy.

• Protease Inhibitor Cocktail: Product Overview

  2026-10-05

  K4001 is a supplier-described 50X DMSO protease inhibitor blend for conceptual protein degradation prevention during extraction, with no matched paper evidence available for product-specific performance.

• Five Questions About dNTPs and LNP Delivery

  2026-10-05

  A source-grounded guide to what a 10 mM dNTP mixture is, what recent LNP research actually shows, how strong the evidence is, and where interpretation must stop.

• HyperScribe™ Poly(A) Tailing: Research Context

  2026-10-04

  The HyperScribe™ Poly (A) Tailing Kit is described by APExBIO as an E. coli Poly (A) Polymerase-based reagent set for adding poly(A) tails to in vitro-transcribed RNA. This overview separates supplier claims from findings in a recent study of endosome-associated lc3b mRNA and local translation in neuronal axons. It explains where enzymatic polyadenylation may support conceptual expression and RNA-localization studies, while emphasizing that the supplied study did not validate this product, does not establish an optimal tail length, and cannot be used to infer clinical or therapeutic performance.

• Caspase-3 Fluorometric Assay Kit: From Signal to Mechanism

  2026-10-03

  The Caspase-3 Fluorometric Assay Kit provides a functional view of DEVD-dependent protease activity in apoptosis research. This article explains how to interpret fluorometric signals mechanistically, using renal cancer evidence to distinguish caspase activation from broader cell-death conclusions.

• Single-Molecule Screening of Fast-Dissociating Antibodies

  2026-10-02

  Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific antibodies with unusually rapid dissociation directly from hybridoma cultures. The resulting Fab probes supported multiplex super-resolution imaging and revealed rapid espin turnover within long-lived actin cores of inner-ear stereocilia, showing that fast exchange can be experimentally useful rather than simply a loss of affinity.

• CGP 55845 Hydrochloride in Synaptic Assays

  2026-10-01

  CGP 55845 hydrochloride provides a receptor-level control for separating GABAB signaling from astrocytic GAT-3 mechanisms in dentate gyrus experiments. This guide translates the reference study into practical in vitro neurotransmission assay workflows, dose-selection logic, controls, and troubleshooting strategies.

• Homoharringtonine Workflows for Cancer Research

  2026-10-01

  Homoharringtonine connects mechanistic leukemia research with emerging SARS-CoV-2 antiviral research through selective disruption of eukaryotic protein synthesis. This practical guide covers solvent handling, assay design, controls, cross-domain interpretation, and troubleshooting for reproducible bench workflows.

• Magnetic Stimulation Targets GABRE in Schizophrenia

  2026-09-30

  The reference study identifies GABRE, encoding the GABAA receptor ε subunit, as a region-specific molecular target of selective magnetic stimulation in the left prelimbic cortex. By combining c-MSST, pharmacological modeling, genetic manipulation, behavioral testing, and synaptic analyses, the authors connect GABRE regulation with the reversal of schizophrenia-like phenotypes in mice.

• AST 487: KDM4A Inhibitor Evidence Guide

  2026-09-30

  AST 487 is a research compound used in the context of KDM4A inhibition in malignant pleural mesothelioma models. The available evidence supports a preclinical role for KDM4A blockade in reducing mesothelioma-cell growth, but it does not establish clinical efficacy, dosing, or product-specific potency.

• Novel Allosteric PDK4 Inhibitors: Study Analysis

  2026-09-29

  Jeon and colleagues developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent biochemical lead. The study connects enzyme inhibition with metabolic, allergic, cellular, pharmacokinetic, and docking data, while also illustrating the limits of translating preclinical PDK4 activity into therapeutic claims.

• YAP–TEAD Control of Surface Ectoderm Commitment

  2026-09-29

  A 2026 Nucleic Acids Research study maps how super-enhancer architecture and three-dimensional chromatin contacts shape early surface ectoderm commitment from pluripotent stem cells. CRISPR-dCas9 perturbation, transcription-factor network analysis, and YAP–TEAD manipulation identify TEAD activity as an upstream driver of super-enhancer establishment and lineage-associated gene activation.

8169 records 1/545 page Next 12345 下5页 Last page